Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

EXPERTS have revealed the golden dose of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

Researchers say GLP-1 medicines might be able to help with migraines.

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...